Open AccessComparison of biparametric MRI to full multiparametric MRI for detection of clinically significant prostate cancer
Author(s) -
R. Lynn Sherrer,
Zachary A. Glaser,
Jennifer Gordetsky,
Jeffrey Nix,
Kristin K. Porter,
Soroush RaisBahrami
Publication year - 2018
Publication title -
prostate cancer and prostatic diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2
H-Index - 64
eISSN - 1476-5608
pISSN - 1365-7852
DOI - 10.1038/s41391-018-0107-0
Subject(s) - medicine , magnetic resonance imaging , prostate cancer , biopsy , radiology , cancer , multiparametric mri , diffusion mri , prostate , nuclear medicine
Multiparametric magnetic resonance imaging (MP-MRI) and MRI/ultrasound (US) fusion-guided biopsy are becoming more widely used techniques for prostate cancer (PCa) diagnosis and management. However, their widespread adoption and use, where available, are limited by cost and added time. These limitations could be minimized if a biparametric MRI (BP-MRI) focusing on T2-weighted and diffusion-weighted imaging is performed. Herein we report the cancer detection rate of BP-MRI compared with full MP-MRI.